Company Filing History:
4 out of 4,446 
2 out of 2 Years Active: 2005-2014
Title: John Cunningham O'Toole: Innovator in Pharmaceutical Chemistry
Introduction
John Cunningham O'Toole is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target serotonin receptors. With a total of 4 patents to his name, O'Toole's work has implications for treating various mental health disorders.
Latest Patents
O'Toole's latest patents include innovative compounds designed for specific therapeutic applications. One of his inventions provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines, which act as selective 5-HT2c receptor agonists. These compounds are aimed at treating 5-HT2c associated disorders, including obesity, obsessive/compulsive disorder, depression, and anxiety. Another patent focuses on a series of aryl piperazine compounds that serve as effective pharmaceuticals for conditions related to the serotonin 1 receptor. These compounds are particularly useful in alleviating symptoms associated with nicotine and tobacco withdrawal.
Career Highlights
Throughout his career, O'Toole has worked with prominent companies in the pharmaceutical industry. He has been associated with Eli Lilly and Company, a leader in the development of innovative medicines. Additionally, he has contributed his expertise to Avera Pharmaceuticals, Inc., further enhancing his impact in the field.
Collaborations
O'Toole has collaborated with several professionals in his field, including Alexander Glenn Godfrey and Daniel Timothy Kohlman. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
John Cunningham O'Toole's contributions to pharmaceutical chemistry are noteworthy, particularly in the realm of serotonin receptor-targeting compounds. His innovative work continues to influence the treatment of various mental health disorders, showcasing the importance of research and development in the pharmaceutical industry.